Transcatheter Academy

Does earlier TAVR simply start the reintervention clock sooner? Dr @nmbutala explains why early TAVR remained highly cost-effective even when future reintervention was modelled ▶️ More from #TCT2026 on our TCT Congress Hub 👉 radc.life/HX44ldGp #TAVR #AorticStenosis

“As a coronary interventionist going into the next decade or so, you’ve got to know how to look at CT” Dr Ajay Kirtane on CT-guided PCI, plus his take on P4, TRANSFORM II, HD-PCI & REMEDY-PILOT at #TCT2026 🎥 Full highlights on the TCT Congress Hub 👉 radc.life/4BXfMrn0 #LBCT #PCI

In this clip, Prof Andrew Cook explores how previous surgical valve design and implantation position can influence future transcatheter interventions. Prof Andrew Cook reviews a Hancock II surgical bioprosthetic valve and highlights key anatomical considerations, including its supra-annular position and the relationship between the prosthetic frame and surrounding conduction tissue. Although this valve remains functioning well and does not require intervention, the case demonstrates why understanding the original surgical valve design is essential when planning lifetime valve management. The interaction between prosthetic valves, the aortic root anatomy and the conduction system remains an important consideration when evaluating future TAVI strategies. A practical insight into how early valve decisions can shape future treatment options. #TAVI #TAVR #StructuralHeart #ValveInValve #HeartTeam #InterventionalCardiology

Next Era of Structural Heart Imaging 🚨 Ole De Backer discusses the practical integration of intracardiac echocardiography into left atrial appendage closure workflows. He highlights the complementary use of fluoroscopy and ICE during device implantation, using simultaneous visualisation to guide depth, orientation and positioning within the appendage. A key focus is the “ball” configuration technique, ensuring optimal device positioning approximately one centimetre distal to the circumflex artery, supported by ICE-based anatomical marking and real-time confirmation. The session demonstrates how, in selected cases, intracardiac echocardiography alone can guide full LAA closure, supporting precise device deployment through coordinated push and unsheath technique. A practical insight into the evolving role of 3D ICE in simplifying and refining structural heart interventions. #LAAClosure #ICE #3DICE #StructuralHeart #Watchman #InterventionalCardiology #Cardiology

Degenerative mitral valve disease is more prevalent in men, yet the burden of mortality is greater in women. Why? Dr @jgranadacrf explores what this disparity could mean for detection, treatment and access to care ▶️ Explore more insights on the TCT Congress Hub: radc.life/pkTjiAVA #TCT2026 #MitralRegurgitation #Cardiology

Is a two-year follow-up interval still enough for moderate aortic stenosis? With at-risk features common among patients with moderate AS, Prof @PPibarot discusses why PROGRESS supports earlier referral, comprehensive evaluation and a more proactive approach to care ▶️ Explore more from #TCT2026 on the TCT Congress Hub 👉 radc.life/PJjhFgjk #AorticStenosis #TAVR

Is the appeal of stentless PCI moving faster than the evidence? As DCBs expand into de novo coronary disease, where does leaving nothing behind offer a real clinical advantage, and where is stenting still difficult to displace? Dr Ajay Kirtane and Prof @drnvanmieghem examine the boundaries of the stentless strategy at #TCT2026. ▶️ Explore the discussion on the TCT Congress Hub 👉 radc.life/Wbs1lqiB #PCI #DCB #InterventionalCardiology

DCB for de novo PCI: does the risk of vessel occlusion still hold? In TRANSFORM II, a sirolimus-coated balloon strategy was non-inferior to DES for target-lesion failure at 1 year, following successful lesion preparation. Prof @BernardCortese discusses why lesion preparation matters. ▶️ Explore more from #TCT2026 on the TCT Congress Hub: radc.life/lwek0srZ #TCT2026 #DCB #PCI #InterventionalCardiology

🔴 #TCT2026 | PROGRESS Dr Nadira Hamid talks to Prof @PPibarot about PROGRESS in moderate AS + ≥1 at-risk feature: 📉 Death/#HF event: 16.7% vs 23.9% 🏥 HF hospitalisation: 7.4% vs 14.9% “Moderate is not a benign disease.” Prof Philippe Pibarot 🎥 Watch: radc.life/LSeyZj1P #TCT2026 #LBCT #NailItWithNadira #PROGRESS #TAVR #AorticStenosis #CardioTwitter

📈 Looking to optimize procedural efficiency in structural heart interventions? Catch up on this on-demand webinar exploring hemodynamics, pacing, and vascular access strategies 👉 ow.ly/L6Y2510136t Featuring Nicolas Van Mieghem, MD, Vijay Iyer, MD and Azeem Latib, MD, the faculty discuss procedural planning, invasive hemodynamics, LV pacing, and evolving approaches to large-bore vascular access and closure. Plus, gain practical insights through real-world case-based discussion – watch at a time that suits you ▶️ #StructuralHeart #HeartTeam #InterventionalCardiology #Cardiology This program is supported by an unrestricted educational grant from Haemonetics.

17 minutes shorter. 20 ml less contrast. Could CT-guided planning change PCI? P4 showed CT-guided PCI was non-inferior to IVUS guidance at 1 year, alongside reductions in procedural time and contrast use Dr @ColletCarlos and @drnvanmieghem consider a bigger question: could more effective planning before the cath lab reshape how PCI is performed? ▶️ Explore more from #TCT2026 on the TCT Congress Hub: radc.life/y8vSDJdN #PCI #CardiacCT #InterventionalCardiology

TEER or TTVR: when both are feasible, which comes first? Prof @drnvanmieghem and Dr Azeem Latib debate the balance between eliminating TR, RV function and procedural risk, and whether a head-to-head trial is needed ▶️ Explore #TCT2026 on the TCT Congress Hub: radc.life/7PTujeYi #TEER #TTVR #TricuspidRegurgitation

Following an intra-arterial Angio-Seal deployment, how should operators manage common femoral artery thrombus? Dr Azeem Latib shares a practical approach using covered stent placement and highlights the importance of distal runoff imaging to assess below-knee vessel patency. #TAVR #VascularAccess

How Are Leading Interventional Cardiologists Treating Tricuspid Regurgitation? In this upcoming live webinar, Dr Hursh Naik, Dr Anita Asgar and Dr Paul Sorajja review the latest evidence supporting transcatheter tricuspid valve repair with the TriClip™ system. 📅 19 November 2026 ⏰ 16:00 PDT | 19:00 EDT Secure your place today 🔗 transcatheteracademy.com/web… This webinar is supported by Abbott

How can surgical valve choice balance long-term durability with the demands of minimally invasive surgery? In this exclusive interview, Prof Michael Borger provides a surgical perspective on the continuing role of surgical aortic valve replacement in the transcatheter era, particularly for younger patients and those with bicuspid aortic valves, coronary artery disease or other concomitant pathologies. Watch now 👉 transcatheteracademy.com/vid… This interview is sponsored by Abbott.

The TAVI-PCI trial enrolled 986 patients across 48 European sites. At ESC Congress 2026, Prof Barbara Elisabeth Stähli and Prof Albert Markus Kasel discuss the one-year composite primary endpoint comparing PCI-first and TAVI-first strategies. #TAVI #PCI

Would you release here? Leaflet capture assessed. Valve height ~5–7 mm. Now comes the decision to release Follow Dr Firas Zahr and the @OHSUNews team through the full filmed EVOQUE TTVR case on Transcatheter Academy ▶️ Watch the full case on Transcatheter Academy: radc.life/QalZZnFM #TTVR #3DICE

PCI before or after TAVI? At ESC Congress 2026, Prof Barbara Elisabeth Stähli and Prof Albert Markus Kasel explain how the TAVI-PCI trial compared both strategies in patients with severe aortic stenosis and coronary artery disease. #TAVI #PCI

Your EVOQUE position looks good, but your ICE view doesn’t. What’s your next move? Watch Dr Firas Zahr and the structural heart team at @OHSUNews adjust the ICE catheter around the delivery shaft improving visualisation during TTVR ▶️ Watch the full case on Transcatheter Academy: radc.life/9P3Uq8Qy #3DICE #TTVR